Professor John Camm has been Professor of Clinical Cardiology at St. George's Hospital Medical School in London since 1986. He is also an honorary consultant cardiologist at St. George's.
Professor Camm started his medical training at Guy’s Hospital Medical School, London, UK in 1971. After three years working at Guy’s Hospital Medical School, he then spent a year in the USA (Vermont), and subsequently moved to St. Bartholomew's Hospital, London, UK. Whilst there, he progressed from Junior, to Wellcome Senior Lecturer in 1979 and finally to Sir Ronald Bodley Scott Professor of Cardiovascular Medicine in 1983. He has a major interest in cardiovascular safety of cardiac and non-cardiac drugs, as well as other broader aspects including cardiac arrhythmias, clinical cardiac electrophysiology, cardiac pacemakers, risk stratification in post myocardial infarction, heart failure and cardiomyopathy patients.
Professor Camm is a Fellow of The Royal College of Physicians (RCP) and also a Fellow of the American College of Cardiology, the American Heart Association (AHA), the Council of Geriatric Cardiology and the European Society of Cardiology (ESC). Professor Camm is a current board member of the European Heart Rhythm Association and the American College of Cardiology, and the current President of the Arrhythmia Alliance. He is also the Editor in Chief of Europace, the Editor of the European Society of Cardiology Textbook of Cardiovascular Medicine, and an editor of Clinical Cardiology and the European Heart Journal. He is also an editorial board member of a further 15 journals. Professor Camm has given over 1,000 international lectures, and authored more than 1,000 papers in peer-reviewed journals, as well as more than 500 book chapters in over 30 books. He has also received numerous awards for contributions to cardiology, including the European Society of Cardiology Gold Medal and the British Cardiovascular Society Mackenzie Medal.
Professor Ben Freedman is deputy director research strategy, Heart Research Institute/Charles Perkins Centre University of Sydney, and is Professor of Cardiology, Sydney Medical School, University of Sydney. He is head of vascular biology Anzac Research Institute, and Honorary VMO, Concord Repatriation General Hospital. He holds fellowships of the CSANZ, RACP, ACC, ESC and AHA. In 2002, he was Scientific Chairman of the successful World Congress of Cardiology, and he has been an interviewer and editorial board member of ACCEL, the extended learning program of the American College of Cardiology since 1996. His main research focus is atrial fibrillation screening: in 2015 he and the 4 other steering committee members founded AF-SCREEN International Collaboration. In 2011 he was awarded the Order of Australia Medal for service to medicine as a clinician, educator and researcher.
Dr. Jeff Healey MD, MSc is the director of arrhythmia services and professor of medicine at McMaster University in Hamilton, Ontario Canada. He is also a clinical trialist, and member of the Population Health Research Institute. Dr. Healey completed his clinical training in cardiology and electrophysiology at the University of Ottawa Heart Institute and completed his Master’s degree in health research methodology at McMaster University.
Currently, Dr. Healey’s clinically activities involve both catheter ablation and pacemaker/ICD implantation. His research involves the conduct of randomized clinical trials and large registries in the fields of cardiac arrhythmias and cardiac devices. His area of research focus is studying the effect of risk factors, and risk factor modification on the development of atrial fibrillation and its complications, such as stroke.
Dr. Healey has published over 280 manuscripts and abstracts, including 60 manuscripts in the past 2 years (24 as first or last author). Dr. Healey has received numerous grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation and from industry. He is the co-chair of the Canadian Cardiovascular Society’s Atrial Fibrillation Guidelines Committee, co-chair of the CCS Guidelines for Perioperative management of pacemakers and defibrillators and past chair of the Cardiac Care Network of Ontario’s Heart Rhythm Working group.
Dr. Healey is the principal investigator and chair of the Canadian Stroke Prevention Intervention Network (C-SPIN), a ten-year network grant funded by the Canadian Institutes of Health Research, The Heart and Stroke Foundation of Canada and Industry. C-SPIN will conduct a series of clinical trials related to atrial fibrillation and stroke prevention and will also support the development of new Canadian researchers in this field.
Dr. Hugh Calkins is the Nicholas J. Fortuin M.D. Professor of Cardiology and Director of the Electrophysiology Laboratory and Arrhythmia Service at the Johns Hopkins Hospital. He is an internationally recognized expert on catheter ablation, atrial fibrillation, syncope, arrhythmogenic right ventricular dysplasia (ARVD) and arrhythmia management.
Dr. Calkins attended Williams College and Harvard Medical School before training in medicine at Massachusetts General Hospital. He received his cardiology training at Johns Hopkins. His first faculty position was at the University of Michigan, where he directed the Pacemaker Service, and he returned to Johns Hopkins as director of the Arrhythmia Service in 1992.
Dr. Calkins is an Associate Editor of the Journal of Cardiovascular Electrophysiology and is on the editorial board of many other cardiology journals. He is a former member of the American Board of Internal Medicine Electrophysiology Boards Test Writing Committee. Dr. Calkins is a fellow of the American College of Cardiology, the American Heart Association and the Heart Rhythm Society. He led a 44-member international task force whose 2012 Expert Consensus Statement gave recommendations for treatment and research of atrial fibrillation. Dr Calkins is a past president of the Heart Rhythm Society and was elected to be a member of the Miler Coulsen Academy of Clinical Excellence in 2014.
Dr. Calkins has published more than 500 articles and book chapters on a large variety of cardiac arrhythmias. His research has focused predominantly on catheter ablation, atrial fibrillation, syncope, and arrhythmogenic right ventricular dysplasia. Dr. Calkins has also written extensively on most aspects of heart rhythm disorders and their treatment.
Mårten Rosenqvist MD, PhD is Professor of Cardiology at Karolinska Institutet in Stockholm and Senior Consultant at the Dept of Cardiology, Danderyd University Hospital in Stockholm.
PI for the STROKESTOP study
Ji-Guang Wang MD, PhD, FAHA, FESC is professor of cardiovascular medicine at Shanghai Jiaotong University School of Medicine. He is currently director of the Shanghai Institute of Hypertension and director of the Department of Hypertension, Ruijin Hospital. He has published more than 280 full-length articles in the international literature and more than 120 articles in the Chinese literature. He is currently council member of the International Society of Hypertension and president-elect of the Chinese Hypertension League. He serves on the editorial board of several international journals, such as the American Journal of Hypertension, Hypertension (Associate Editor), Hypertension Research (Associate Editor), Journal of Hypertension, etc.
Renate B. Schnabel, MD, MSc is professor of internal medicine-cardiology at University Heart Center Hamburg, Germany. Prof. Schnabel graduated from medical school at Johannes Gutenberg University Mainz. She started her medical training at University Medicine Mainz. She received a master’s of science in epidemiology from Boston University. She performed a research fellowship at the Framingham Heart Study where she developed her keen interest in atrial fibrillation epidemiology. Since then she has co-authored more than 100 peer-review publications on the topic of atrial fibrillation risk prediction. Prof. Schnabel is on the editorial board of several cardiovascular journals. She is member of international consortia dedicated to atrial fibrillation epidemiology and genetics. She works with population cohorts such as the Hamburg City Health Study and clinical studies on atrial fibrillation. Her major research interest is in atrial fibrillation risk assessment and screening using epidemiological and systems medicine approaches. In these research fields she holds national (German Ministry of Education and Research (BMBF), German Research Foundation (DFG)) and EU grants on systems medicine of atrial fibrillation. She has been an enthusiastic member of the AF Screen International Collaboration from early on.